FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2023961961> ?p ?o ?g. }

• W2023961961 endingPage "5918" @default.
• W2023961961 startingPage "5907" @default.
• W2023961961 abstract "Abstract Purpose: Transforming growth factor (TGF)-β blockade has been proposed as an anticancer therapy; however, understanding which tumor patients might benefit most from such therapy is crucial. An ideal target of such inhibitory therapy might be malignant mesothelioma (MM), a highly lethal, treatment-resistant malignancy of mesothelial cells of the pleura and peritoneum that produces large amounts of TGF-β. The purpose of this study was to explore the possible therapeutic utility of TGF-β blockade on MM. Experimental Design: To evaluate this hypothesis, we tested the effects of a soluble TGF-β type II receptor (sTGF-βR) that specifically inhibits TGF-β1 and TGF-β3 in three different murine MM tumor models, AB12 and AC29 (which produce large amounts of TGF-β) and AB1 (which does not produce TGF-β). Results: Tumor growth of both established AB12 and AC29 tumors was inhibited by sTGF-βR. In contrast, AB1 tumors showed little response to sTGF-βR. The mechanism of these antitumor effects was evaluated and determined to be primarily dependent on immune-mediated responses because (a) the antitumor effects were markedly diminished in severe combined immunodeficient mice or mice depleted of CD8+ T cells and (b) CD8+ T cells isolated from spleens of mice treated with sTGF-βR showed strong antitumor cytolytic effects, whereas CD8+ T cells isolated from spleens of tumor-bearing mice treated with of control IgG2a showed no antitumor cytolytic effects. Conclusions: Our data suggest that TGF-β blockade of established TGF-β-secreting MM should be explored as a promising strategy to treat patients with MM and other tumors that produce TGF-β." @default.
• W2023961961 created "2016-06-24" @default.
• W2023961961 creator A5000647160 @default.
• W2023961961 creator A5005953721 @default.
• W2023961961 creator A5007545977 @default.
• W2023961961 creator A5017789289 @default.
• W2023961961 creator A5035091873 @default.
• W2023961961 creator A5072847758 @default.
• W2023961961 creator A5073541895 @default.
• W2023961961 date "2004-09-01" @default.
• W2023961961 modified "2023-09-24" @default.
• W2023961961 title "Soluble Type II Transforming Growth Factor-β Receptor Inhibits Established Murine Malignant Mesothelioma Tumor Growth by Augmenting Host Antitumor Immunity" @default.
• W2023961961 cites W1139223896 @default.
• W2023961961 cites W1503388237 @default.
• W2023961961 cites W1565561072 @default.
• W2023961961 cites W1587849076 @default.
• W2023961961 cites W1781965212 @default.
• W2023961961 cites W1875605274 @default.
• W2023961961 cites W1898762802 @default.
• W2023961961 cites W1938194109 @default.
• W2023961961 cites W1964945438 @default.
• W2023961961 cites W1965568495 @default.
• W2023961961 cites W1966080706 @default.
• W2023961961 cites W1972561967 @default.
• W2023961961 cites W1975470297 @default.
• W2023961961 cites W1976534761 @default.
• W2023961961 cites W1977062776 @default.
• W2023961961 cites W1979877257 @default.
• W2023961961 cites W1985458261 @default.
• W2023961961 cites W1993312145 @default.
• W2023961961 cites W2007768242 @default.
• W2023961961 cites W2008769116 @default.
• W2023961961 cites W2019848611 @default.
• W2023961961 cites W2021107622 @default.
• W2023961961 cites W2032655275 @default.
• W2023961961 cites W2033260397 @default.
• W2023961961 cites W2035404114 @default.
• W2023961961 cites W2040074251 @default.
• W2023961961 cites W2042360792 @default.
• W2023961961 cites W2047375535 @default.
• W2023961961 cites W2048171393 @default.
• W2023961961 cites W2048439815 @default.
• W2023961961 cites W2062025417 @default.
• W2023961961 cites W2072255058 @default.
• W2023961961 cites W2084498901 @default.
• W2023961961 cites W2086821422 @default.
• W2023961961 cites W2087863947 @default.
• W2023961961 cites W2099756285 @default.
• W2023961961 cites W2110458134 @default.
• W2023961961 cites W2129026847 @default.
• W2023961961 cites W2146839556 @default.
• W2023961961 cites W2147018670 @default.
• W2023961961 cites W2149852376 @default.
• W2023961961 cites W2169110793 @default.
• W2023961961 cites W4229714030 @default.
• W2023961961 cites W4240924668 @default.
• W2023961961 cites W4248052112 @default.
• W2023961961 doi "https://doi.org/10.1158/1078-0432.ccr-03-0611" @default.
• W2023961961 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/15355924" @default.
• W2023961961 hasPublicationYear "2004" @default.
• W2023961961 type Work @default.
• W2023961961 sameAs 2023961961 @default.
• W2023961961 citedByCount "63" @default.
• W2023961961 countsByYear W20239619612012 @default.
• W2023961961 countsByYear W20239619612013 @default.
• W2023961961 countsByYear W20239619612014 @default.
• W2023961961 countsByYear W20239619612015 @default.
• W2023961961 countsByYear W20239619612016 @default.
• W2023961961 countsByYear W20239619612017 @default.
• W2023961961 countsByYear W20239619612018 @default.
• W2023961961 countsByYear W20239619612019 @default.
• W2023961961 countsByYear W20239619612020 @default.
• W2023961961 countsByYear W20239619612023 @default.
• W2023961961 crossrefType "journal-article" @default.
• W2023961961 hasAuthorship W2023961961A5000647160 @default.
• W2023961961 hasAuthorship W2023961961A5005953721 @default.
• W2023961961 hasAuthorship W2023961961A5007545977 @default.
• W2023961961 hasAuthorship W2023961961A5017789289 @default.
• W2023961961 hasAuthorship W2023961961A5035091873 @default.
• W2023961961 hasAuthorship W2023961961A5072847758 @default.
• W2023961961 hasAuthorship W2023961961A5073541895 @default.
• W2023961961 hasConcept C118131993 @default.
• W2023961961 hasConcept C126322002 @default.
• W2023961961 hasConcept C142724271 @default.
• W2023961961 hasConcept C154317977 @default.
• W2023961961 hasConcept C167672396 @default.
• W2023961961 hasConcept C170493617 @default.
• W2023961961 hasConcept C202751555 @default.
• W2023961961 hasConcept C203014093 @default.
• W2023961961 hasConcept C2777407522 @default.
• W2023961961 hasConcept C2777701055 @default.
• W2023961961 hasConcept C2778229498 @default.
• W2023961961 hasConcept C2778468042 @default.
• W2023961961 hasConcept C502942594 @default.
• W2023961961 hasConcept C55493867 @default.
• W2023961961 hasConcept C71924100 @default.
• W2023961961 hasConcept C73588182 @default.
• W2023961961 hasConcept C86803240 @default.

• next